GLP-1 receptor agonist use may be associated with a modest increase in erectile dysfunction (ED) risk in men with type 2 ...

Compared to those without diabetes, men with diabetes have an increased risk of developing erectile dysfunction. Beta‐blockers can reduce testosterone levels and cause vasoconstriction in the penile ...

Erectile dysfunction (ED) impacts an estimated 18 million men in the U.S. alone, yet it is rarely discussed openly. John Smith, DO, a urologist at University of Utah Health, addresses the barriers to ...

UVA is conducting a clinical trial exploring the potential of low-intensity shockwave therapy to address erectile dysfunction by promoting new blood vessel growth and tissue repair. The federal Food ...